CONCLUSION: Preclinical studies, animal studies, and early clinical trials in humans have shown a promising role of LDRT in the treatment of AD pathologies, although the underlying mechanisms are yet to be fully explored. Phase I/II/III trials are needed to assess the long-term safety, efficacy, and optimal treatment parameters of LDRT in AD …